ENDURANT CAPITAL MANAGEMENT LP – BioMarin Pharmaceutical Inc. Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$12.32M
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +459.67% | 119.39K shares | 10.17M | $84.77 | 145.37K |
| Q2 2022 | share | Increase | 0.00% | 25.97K shares | 2.15M | $82.87 | 25.97K |
| Q2 2020 | share | Decrease | -100.00% | -28.59K shares | -2.41M | $123.34 | 0 |
| Q1 2020 | share | Increase | 0.00% | 28.59K shares | 2.41M | $84.5 | 28.59K |
| Q1 2018 | share | Decrease | -100.00% | -10.1K shares | -901K | $81.07 | 0 |
| Q4 2017 | share | Increase | 0.00% | 10.1K shares | 901K | $89.17 | 10.1K |
| Q3 2017 | share | Decrease | -100.00% | -9.3K shares | -845K | $93.07 | 0 |
| Q2 2017 | share | Increase | +82.35% | 4.2K shares | 397K | $90.82 | 9.3K |
| Q1 2017 | share | Increase | 0.00% | 5.1K shares | 448K | $87.78 | 5.1K |